Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rigel Pharmaceuticals has announced the pricing of its public offering of 5 million shares of common stock at a price of $27 per share. All of the shares are being offered by Rigel.
Subscribe to our email newsletter
The underwriters have an option to purchase up to an additional 750,000 shares to cover over-allotments, if any. The offering is expected to close on February 6, 2008, subject to the satisfaction of customary closing conditions.
Credit Suisse Securities (USA) is acting as the sole book-runner for the offering, with Thomas Weisel Partners, Jefferies & Company, and Oppenheimer & Co. acting as co-managers.